| scholarly article | Q13442814 |
| P50 | author | Carol A. Barnes | Q5044216 |
| P2093 | author name string | Audrey Duarte | |
| Tatjana Rundek | |||
| Lee Ryan | |||
| Matthias R Mehl | |||
| Bonnie Levin | |||
| Anja Soldan | |||
| Meredith Hay | |||
| Matt J Huentelman | |||
| Corinne Pettigrew | |||
| P2860 | cites work | Age-related neuroinflammatory changes negatively impact on neuronal function | Q21128630 |
| Computerized cognitive training in cognitively healthy older adults: a systematic review and meta-analysis of effect modifiers | Q21144589 | ||
| A protein factor essential for microtubule assembly | Q22010837 | ||
| Cancer genome landscapes | Q22242276 | ||
| In vivo cortical spreading pattern of tau and amyloid in the Alzheimer disease spectrum. | Q48665805 | ||
| Cognitive and brain changes associated with ischaemic heart disease and heart failure. | Q48681275 | ||
| Indicators of job strain at midlife and cognitive functioning in advanced old age. | Q48919428 | ||
| Cognitive impairment and white matter damage in hypertension: a pilot study. | Q48922227 | ||
| Epigenome-Wide Association Study of Cognitive Functioning in Middle-Aged Monozygotic Twins. | Q49623121 | ||
| Normal aging induces A1-like astrocyte reactivity. | Q50043361 | ||
| The Effects of Chronic Stress on the Human Brain: From Neurotoxicity, to Vulnerability, to Opportunity. | Q50112276 | ||
| Evaluating Cognitive Reserve Through the Prism of Preclinical Alzheimer Disease. | Q50140579 | ||
| Markers of low-grade inflammation and endothelial dysfunction are related to reduced information processing speed and executive functioning in an older population - the Hoorn Study. | Q50662371 | ||
| Distress proneness and cognitive decline in a population of older persons. | Q50748610 | ||
| Systemic markers of inflammation and cognitive decline in old age. | Q50804243 | ||
| Impact of Nitric Oxide Bioavailability on the Progressive Cerebral and Peripheral Circulatory Impairments During Aging and Alzheimer's Disease. | Q51758674 | ||
| Cerebrospinal fluid biomarkers predict decline in subjective cognitive function over 3 years in healthy elderly. | Q51901649 | ||
| Heart failure and risk of dementia and Alzheimer disease: a population-based cohort study. | Q51917859 | ||
| Age-associated alterations of hippocampal place cells are subregion specific. | Q51990282 | ||
| Inflammation markers in relation to cognition in a healthy aging population. | Q52008621 | ||
| Environment-specific expression of the immediate-early gene Arc in hippocampal neuronal ensembles. | Q52894389 | ||
| Elevated body mass index is associated with executive dysfunction in otherwise healthy adults. | Q53283282 | ||
| Familial Alzheimer disease: decreases in CSF Abeta42 levels precede cognitive decline. | Q53372684 | ||
| Comparison of polarization properties of human adult microglia and blood-derived macrophages | Q57041309 | ||
| Lower cognitive function in the presence of obesity and hypertension: the Framingham heart study | Q57506033 | ||
| Vascular dementia | Q57813319 | ||
| Relationships Among Cognitive Function and Cerebral Blood Flow, Oxidative Stress, and Inflammation in Older Heart Failure Patients | Q57932611 | ||
| A High Plasma Concentration of TNF- Is Associated With Dementia in Centenarians | Q59326375 | ||
| Cognitive decline and dementia in diabetes mellitus: mechanisms and clinical implications. | Q64882401 | ||
| Diabetes as a risk factor for dementia and mild cognitive impairment: a meta-analysis of longitudinal studies | Q83528586 | ||
| Aging in the Brain: New Roles of Epigenetics in Cognitive Decline | Q89019047 | ||
| Combined neuropathological pathways account for age-related risk of dementia | Q89259517 | ||
| Whitepaper: Defining and investigating cognitive reserve, brain reserve, and brain maintenance | Q91484039 | ||
| Microglia in neurodegeneration | Q91786444 | ||
| Hilar interneuron vulnerability distinguishes aged rats with memory impairment | Q36710124 | ||
| The role of cerebrovascular disease when there is concomitant Alzheimer disease | Q36731049 | ||
| Deficiency in mural vascular cells coincides with blood-brain barrier disruption in Alzheimer's disease | Q36773984 | ||
| The Science of Vascular Contributions to Cognitive Impairment and Dementia (VCID): A Framework for Advancing Research Priorities in the Cerebrovascular Biology of Cognitive Decline | Q36877518 | ||
| Body mass index and magnetic resonance markers of brain integrity in adults | Q36889018 | ||
| Transcription Profile of Aging and Cognition-Related Genes in the Medial Prefrontal Cortex | Q36906158 | ||
| Tracking the course of hippocampal representations during learning: when is the map required? | Q36979375 | ||
| Frequent amyloid deposition without significant cognitive impairment among the elderly | Q37085957 | ||
| Inverse association between BMI and prefrontal metabolic activity in healthy adults | Q37189405 | ||
| Longitudinal cognitive performance in older adults with cardiovascular disease: evidence for improvement in heart failure | Q37238094 | ||
| Elevated levels of interleukin 6 and C-reactive protein associated with cognitive impairment in heart failure | Q37240976 | ||
| Rate of conversion from prodromal Alzheimer's disease to Alzheimer's dementia: a systematic review of the literature | Q37255097 | ||
| Predicting risk of dementia in older adults: The late-life dementia risk index | Q37274596 | ||
| The effects of exercise on cognition in older adults with and without cognitive decline: a systematic review. | Q37323218 | ||
| Relationship of cognitive reserve and APOE status to the emergence of clinical symptoms in preclinical Alzheimer's disease | Q37333103 | ||
| Efficiency, capacity, compensation, maintenance, plasticity: emerging concepts in cognitive reserve. | Q37343322 | ||
| Blood pressure and the risk for dementia: a double edged sword. | Q37343657 | ||
| Much of late life cognitive decline is not due to common neurodegenerative pathologies. | Q37354720 | ||
| The neuroendocrinology of social isolation | Q37458173 | ||
| The worldwide costs of dementia 2015 and comparisons with 2010 | Q37583404 | ||
| Biomarker modeling of Alzheimer's disease | Q37592824 | ||
| Aging-dependent changes of microglial cells and their relevance for neurodegenerative disorders | Q37651028 | ||
| Association of type 2 diabetes with brain atrophy and cognitive impairment | Q37665715 | ||
| Senescent synapses and hippocampal circuit dynamics | Q37673419 | ||
| Endothelial nitric oxide: protector of a healthy mind | Q37687314 | ||
| Targets for the prevention of dementia | Q37736188 | ||
| microRNAs in neurons: manifold regulatory roles at the synapse | Q37874365 | ||
| CSF biomarkers for amyloid and tau pathology in Alzheimer's disease | Q37953330 | ||
| Social neuroscience and health: neurophysiological mechanisms linking social ties with physical health | Q38002730 | ||
| Inflammation, defective insulin signaling, and neuronal dysfunction in Alzheimer's disease | Q38188178 | ||
| A review of physical and cognitive interventions in aging | Q38202506 | ||
| The impact of exercise on the cognitive functioning of healthy older adults: a systematic review and meta-analysis | Q38214945 | ||
| Is pathological aging a successful resistance against amyloid-beta or preclinical Alzheimer's disease? | Q38230389 | ||
| Confluence of α-synuclein, tau, and β-amyloid pathologies in dementia with Lewy bodies | Q38311234 | ||
| Dystrophic microglia in the aging human brain | Q48090856 | ||
| Positive effects of combined cognitive and physical exercise training on cognitive function in older adults with mild cognitive impairment or dementia: A meta-analysis | Q48112750 | ||
| Neuropathology of cognitively normal elderly | Q48125911 | ||
| The Aging Navigational System | Q48132574 | ||
| Sleep disturbance is associated with incident dementia and mortality | Q48162950 | ||
| Age-related alterations in potentiation in the CA1 region in F344 rats | Q48296539 | ||
| Chronic distress, age-related neuropathology, and late-life dementia | Q48300376 | ||
| Impact of Alzheimer's pathology on cognitive trajectories in nondemented elderly | Q48326005 | ||
| Differing associations between Aβ accumulation, hypoperfusion, blood-brain barrier dysfunction and loss of PDGFRB pericyte marker in the precuneus and parietal white matter in Alzheimer's disease | Q48328265 | ||
| Structural brain differences and cognitive functioning related to body mass index in older females. | Q48383706 | ||
| Cerebrospinal fluid beta-amyloid 42 is reduced before the onset of sporadic dementia: a population-based study in 85-year-olds. | Q48388907 | ||
| The vascular factor in Alzheimer's disease: a study in Golgi technique and electron microscopy. | Q48420632 | ||
| Age‐related loss of axospinous synapses formed by two afferent systems in the rat dentate gyrus as revealed by the unbiased stereological dissector technique | Q48429040 | ||
| The suprachiasmatic nucleus of the human brain in relation to sex, age and senile dementia. | Q48453920 | ||
| Phenotyping primary human microglia: tight regulation of LPS responsiveness. | Q48458622 | ||
| Synaptophysin protein and mRNA expression in the human hippocampal formation from birth to old age. | Q48483805 | ||
| Interleukin-6 and risk of cognitive decline: MacArthur studies of successful aging. | Q48511420 | ||
| DNA microarray analysis of the aging brain. | Q48646470 | ||
| Cerebral Hypoperfusion and the Energy Deficit in Alzheimer's Disease. | Q48663991 | ||
| Blood pressure lowering in patients without prior cerebrovascular disease for prevention of cognitive impairment and dementia | Q24240206 | ||
| Epigenetic differences arise during the lifetime of monozygotic twins | Q24531005 | ||
| Five years of GWAS discovery | Q24610574 | ||
| Perceived social isolation and cognition | Q24646698 | ||
| Targeting innate immunity for neurodegenerative disorders of the central nervous system | Q26744219 | ||
| How does it STAC up? Revisiting the scaffolding theory of aging and cognition | Q26827532 | ||
| Cognitive change in heart failure: a systematic review | Q26851605 | ||
| Disconnected aging: cerebral white matter integrity and age-related differences in cognition | Q26852104 | ||
| Age-dependent dysregulation of innate immunity | Q27022410 | ||
| A dural lymphatic vascular system that drains brain interstitial fluid and macromolecules | Q27308814 | ||
| Structural and functional features of central nervous system lymphatic vessels | Q27316769 | ||
| Resting microglial cells are highly dynamic surveillants of brain parenchyma in vivo | Q27860578 | ||
| Emerging roles of exosomes in normal and pathological conditions: new insights for diagnosis and therapeutic applications | Q28081849 | ||
| Monetary costs of dementia in the United States | Q28288245 | ||
| Arc, a growth factor and activity-regulated gene, encodes a novel cytoskeleton-associated protein that is enriched in neuronal dendrites | Q28574732 | ||
| Sleep, cognition, and normal aging: integrating a half century of multidisciplinary research | Q28651715 | ||
| A clockwork web: circadian timing in brain and periphery, in health and disease | Q29618069 | ||
| A systematic review of the psychobiological burden of informal caregiving for patients with dementia: Focus on cognitive and biological markers of chronic stress. | Q30240077 | ||
| A proposed panel of biomarkers of healthy ageing. | Q30370838 | ||
| Increased susceptibility to induction of long-term depression and long-term potentiation reversal during aging | Q30468879 | ||
| Sustained hippocampal IL-1beta overexpression impairs contextual and spatial memory in transgenic mice | Q30477209 | ||
| Narp regulates homeostatic scaling of excitatory synapses on parvalbumin-expressing interneurons | Q30496836 | ||
| Brain changes underlying cognitive dysfunction in diabetes: what can we learn from MRI? | Q30831253 | ||
| Structural imaging measures of brain aging | Q30844186 | ||
| Circuit-specific alterations in hippocampal synaptophysin immunoreactivity predict spatial learning impairment in aged rats. | Q30913232 | ||
| Specific white matter tissue microstructure changes associated with obesity | Q31004529 | ||
| Diffusion tensor imaging and aging | Q31051489 | ||
| Brain reserve and dementia: a systematic review | Q33224644 | ||
| The incidence of co-morbidities related to obesity and overweight: a systematic review and meta-analysis | Q33422129 | ||
| Neurotoxic reactive astrocytes are induced by activated microglia | Q33602850 | ||
| NPTX2 and cognitive dysfunction in Alzheimer's Disease. | Q33602969 | ||
| Synaptic genes are extensively downregulated across multiple brain regions in normal human aging and Alzheimer's disease | Q33616828 | ||
| Modifiable predictors of dementia in mild cognitive impairment: a systematic review and meta-analysis | Q38362386 | ||
| Innate immunity and the failing heart: the cytokine hypothesis revisited | Q38393039 | ||
| Summary of the evidence on modifiable risk factors for cognitive decline and dementia: A population-based perspective | Q38516632 | ||
| Dissecting the Contribution of Vascular Alterations and Aging to Alzheimer's Disease | Q38542827 | ||
| Immunosenescence of microglia and macrophages: impact on the ageing central nervous system. | Q38749164 | ||
| Neuronal Pentraxin 2 predicts medial temporal atrophy and memory decline across the Alzheimer's disease spectrum | Q38839061 | ||
| MicroRNAs in brain aging | Q39101525 | ||
| The aging clock: circadian rhythms and later life | Q39113313 | ||
| Detectable Neuropsychological Differences in Early Preclinical Alzheimer's Disease: A Meta-Analysis | Q39301541 | ||
| Glycolytic oligodendrocytes maintain myelin and long-term axonal integrity | Q39492965 | ||
| Screening for cognitive deficits using the Montreal cognitive assessment tool in outpatients ≥65 years of age with heart failure | Q39784170 | ||
| CNS-wide Sexually Dimorphic Induction of the Major Histocompatibility Complex 1 Pathway With Aging | Q40087375 | ||
| Prognostic serum miRNA biomarkers associated with Alzheimer's disease shows concordance with neuropsychological and neuroimaging assessment. | Q40231224 | ||
| Memory deficits associated with senescence: A neurophysiological and behavioral study in the rat | Q40232008 | ||
| Diabetes and Aging: Unique Considerations and Goals of Care | Q40281876 | ||
| Age of onset of hypertension and risk of dementia in the oldest-old: The 90+ Study | Q40370973 | ||
| Potential Roles of Exosomal MicroRNAs as Diagnostic Biomarkers and Therapeutic Application in Alzheimer's Disease | Q41099377 | ||
| DNA Methylation of Synaptic Genes in the Prefrontal Cortex Is Associated with Aging and Age-Related Cognitive Impairment | Q41203166 | ||
| Inhibition of activity-dependent arc protein expression in the rat hippocampus impairs the maintenance of long-term potentiation and the consolidation of long-term memory. | Q41736768 | ||
| Age-related changes in Egr1 transcription and DNA methylation within the hippocampus. | Q41834725 | ||
| Major Shifts in Glial Regional Identity Are a Transcriptional Hallmark of Human Brain Aging | Q41848600 | ||
| Cyclooxygenase-1 mediates prostaglandin E(2) elevation and contextual memory impairment in a model of sustained hippocampal interleukin-1beta expression | Q42737833 | ||
| Physiology: Inflammation links ageing to the brain | Q42806430 | ||
| MiR-134-dependent regulation of Pumilio-2 is necessary for homeostatic synaptic depression. | Q43088837 | ||
| Mediators of the relationship between life events and memory functioning in a community sample of adults. | Q43160712 | ||
| 2014 Alzheimer's disease facts and figures | Q43520458 | ||
| Body mass index, other cardiovascular risk factors, and hospitalization for dementia | Q43821126 | ||
| Cognitive function in the prefrailty and frailty syndrome. | Q44091106 | ||
| A 32-year prospective study of change in body weight and incident dementia: the Honolulu-Asia Aging Study | Q44360040 | ||
| Gene Microarrays in Hippocampal Aging: Statistical Profiling Identifies Novel Processes Correlated with Cognitive Impairment | Q44433403 | ||
| Relation between body mass index and cognitive function in healthy middle-aged men and women. | Q44583961 | ||
| The 87%. | Q44623938 | ||
| Central obesity and the aging brain | Q44821306 | ||
| Effects of age and hypertension status on cognition: the Veterans Affairs Normative Aging Study | Q45332910 | ||
| Sleep and Human Aging. | Q46025057 | ||
| Subjective Cognitive Decline Modifies the Relationship Between Cerebral Blood Flow and Memory Function in Cognitively Normal Older Adults | Q46081843 | ||
| Overweight and obesity in old age are not associated with greater dementia risk | Q46191719 | ||
| High blood pressure and cerebral white matter lesion progression in the general population | Q46400752 | ||
| Body mass index and cognitive decline in a biracial community population | Q46551768 | ||
| Hippocampal Transcriptomic Profiles: Subfield Vulnerability to Age and Cognitive Impairment | Q47251487 | ||
| Feelings of loneliness, but not social isolation, predict dementia onset: results from the Amsterdam Study of the Elderly (AMSTEL). | Q47561336 | ||
| Sleep in Alzheimer's Disease - Beyond Amyloid | Q47586083 | ||
| Aging is associated with chronic innate immune activation and dysregulation of monocyte phenotype and function. | Q47608596 | ||
| Association of Peripheral Interleukin-6 with Global Cognitive Decline in Non-demented Adults: A Meta-Analysis of Prospective Studies. | Q47718273 | ||
| Chronic stress from adolescence to aging in the prefrontal cortex: A neuroimmune perspective | Q47906167 | ||
| Longitudinal Magnetic Resonance Imaging Studies of Older Adults: A Shrinking Brain | Q47950183 | ||
| Narp, a novel member of the pentraxin family, promotes neurite outgrowth and is dynamically regulated by neuronal activity. | Q48064825 | ||
| Multiple indicators of age-related differences in cerebral white matter and the modifying effects of hypertension | Q33637121 | ||
| Longitudinal cognitive decline is associated with fibrillar amyloid-beta measured by [11C]PiB | Q33730370 | ||
| High adiposity: risk factor for dementia and Alzheimer's disease? | Q33752042 | ||
| Age-related dopamine D2/D3 receptor loss in extrastriatal regions of the human brain | Q33919990 | ||
| Age-related changes in Arc transcription and DNA methylation within the hippocampus. | Q33925933 | ||
| Obesity in middle age and future risk of dementia: a 27 year longitudinal population based study | Q33941073 | ||
| Impact of aging on hippocampal function: plasticity, network dynamics, and cognition | Q33966134 | ||
| Neuropsychological profile in a large group of heart transplant candidates | Q34105183 | ||
| Interleukin-6, age, and corpus callosum integrity | Q34133815 | ||
| Volume of white matter hyperintensities in healthy adults: contribution of age, vascular risk factors, and inflammation-related genetic variants | Q34213287 | ||
| An 18-year follow-up of overweight and risk of Alzheimer disease | Q34214251 | ||
| Perceived stress and change in cognitive function among adults 65 years and older | Q34289978 | ||
| Neuropathologic studies of the Baltimore Longitudinal Study of Aging (BLSA) | Q34298372 | ||
| Age-related differences in white matter integrity and cognitive function are related to APOE status | Q34380707 | ||
| Overview of persistent pain in older adults. | Q34404968 | ||
| The pathogenesis of senile plaques | Q34421483 | ||
| Primary age-related tauopathy (PART): a common pathology associated with human aging | Q34445021 | ||
| Systemic inflammation and the brain: novel roles of genetic, molecular, and environmental cues as drivers of neurodegeneration | Q34463760 | ||
| The precision medicine initiative: a new national effort | Q34474452 | ||
| Tau aggregation influences cognition and hippocampal atrophy in the absence of beta-amyloid: a clinico-imaging-pathological study of primary age-related tauopathy (PART). | Q34550595 | ||
| Prevalence of mixed pathologies in the aging brain | Q34551519 | ||
| Impairment of paravascular clearance pathways in the aging brain | Q34577109 | ||
| Arc/Arg3.1 is essential for the consolidation of synaptic plasticity and memories. | Q34579673 | ||
| Relation of obesity to cognitive function: importance of central obesity and synergistic influence of concomitant hypertension. The Framingham Heart Study | Q34653853 | ||
| Age-related memory deficits linked to circuit-specific disruptions in the hippocampus | Q35008262 | ||
| Body mass and white matter integrity: the influence of vascular and inflammatory markers | Q35023378 | ||
| Amyloid imaging and memory change for prediction of cognitive impairment | Q35029095 | ||
| Vascular risk factors and longitudinal changes on brain MRI: the ARIC study | Q35047530 | ||
| Impact of sleep on the risk of cognitive decline and dementia | Q35069225 | ||
| White matter deterioration in 15 months: latent growth curve models in healthy adults | Q35091208 | ||
| Vascular and amyloid pathologies are independent predictors of cognitive decline in normal elderly | Q35119419 | ||
| Physical frailty is associated with incident mild cognitive impairment in community-based older persons | Q35148154 | ||
| Blood-brain barrier breakdown in the aging human hippocampus | Q35151019 | ||
| Alpha-synuclein levels in blood plasma decline with healthy aging | Q35284843 | ||
| Cerebrospinal fluid biomarkers, education, brain volume, and future cognition | Q35469471 | ||
| Inter-individual variation in blood pressure is associated with regional white matter integrity in generally healthy older adults | Q35532527 | ||
| Association of C-reactive protein with cognitive impairment | Q35591752 | ||
| Diabetes in midlife and cognitive change over 20 years: a cohort study | Q35608514 | ||
| Risk and protective factors for cognitive impairment in persons aged 85 years and older | Q35611682 | ||
| Immune aging, dysmetabolism, and inflammation in neurological diseases | Q35677347 | ||
| Measures of adiposity and dementia risk in elderly persons | Q35678012 | ||
| An anti-diabetes agent protects the mouse brain from defective insulin signaling caused by Alzheimer's disease- associated Aβ oligomers | Q35858008 | ||
| Depression and risk of developing dementia | Q35891902 | ||
| Cognitive profiles in heart failure: a cluster analytic approach | Q35926372 | ||
| White matter integrity in older females is altered by increased body fat. | Q35990485 | ||
| Cerebrospinal fluid beta-amyloid 1-42 concentration may predict cognitive decline in older women | Q36227420 | ||
| MicroRNAs, miR-23a-3p and miR-151-3p, Are Regulated in Dentate Gyrus Neuropil following Induction of Long-Term Potentiation In Vivo | Q36261029 | ||
| Alzheimer's disease cerebrospinal fluid biomarker in cognitively normal subjects | Q36276506 | ||
| Aging and Circadian Rhythms | Q36289275 | ||
| Cognitive decline and dementia in diabetes--systematic overview of prospective observational studies | Q36311526 | ||
| Interactive effects of subjective memory complaints and hypertension on learning and memory performance in the elderly | Q36373375 | ||
| Midlife and late-life obesity and the risk of dementia: cardiovascular health study | Q36441882 | ||
| Differential effects of experience on tuning properties of macaque MTL neurons in a passive viewing task | Q36509352 | ||
| FTO genotype is associated with phenotypic variability of body mass index | Q36588857 | ||
| Causes, consequences, and reversal of immune system aging | Q36638131 | ||
| PET Imaging of Tau Deposition in the Aging Human Brain. | Q36654193 | ||
| Inflammaging and anti-inflammaging: a systemic perspective on aging and longevity emerged from studies in humans | Q36658296 | ||
| Fat mass and obesity gene and cognitive decline: the Atherosclerosis Risk in Communities Study | Q36659415 | ||
| The ageing cortical synapse: hallmarks and implications for cognitive decline | Q36668062 | ||
| Cognitive impairment in heart failure: a systematic review of the literature | Q36686297 | ||
| P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P304 | page(s) | 128 | |
| P577 | publication date | 2019-06-07 | |
| P1433 | published in | Frontiers in Aging Neuroscience | Q21968084 |
| P1476 | title | Precision Aging: Applying Precision Medicine to the Field of Cognitive Aging | |
| P478 | volume | 11 |
Search more.